GCI Nutrients’ Cetyl Myristoleate (CM) is a fatty acid complex with a specified amount of cetyl myristoleate, along with several other fatty acids (including cetyl myristate, cetyl palmitate, cetyl laurate, cetyl palmitoleate, and cetyl oleate). CM is the cetyl ester of the fatty acid myristoleic acid (cis-9- tetradecenoic acid). It occurs in nature in whales’ sperm, in mice, and in the oil glands of male beavers. During the time he was a researcher at the National Institutes of Health, Harry Diehl isolated cetyl myristoleate from the Swiss albino mouse when looking for a treatment for arthritis. He received two U.S. Patents on cetyl myristoleate: U.S. Patent # 4049824: Cetyl Myristoleate (September 20, 1977) and U.S. Patent # 5569676: Method for the treatment of osteoarthritis (October 29, 1996). Diehl’s OwnTM CM is made by reacting fatty acids, including myristoleic acid derived from beef tallow, with cetyl alcohol. Diehl’s OwnTM CM 20% Powder is standardized to 20% CM.
Nutriceutical Properties
Cetyl myristoleate acts as a surfactant to lubricate the joints and connective tissues, regulates prostaglandin and leukotriene production, and acts as an immuno-modulator.
